Raaj Medisafe shares closed at 73.86 on February 14, 2025 (BSE) and has given -30.35% returns over the last 6 months and 40.69% over last 12 months. Reported Standalone quarterly numbers for Raaj Med isafe India are: Net Sales at Rs 14.59 crore in December 2024 up 43.43% from Rs. 10.17 crore in Dec 2023. Net Profit at Rs. 1.03 crore inDec 2024 up 9.09% from. Rs. 0.94 crore. EBITDA stands at £2.20 crore inDecember 2024 up 44.74% from £1.52 crore. RaajMed India’s EPS has decreased to Rs.0.76 in Dec 2024 from 0.86 in December 2023, according to BSE data. The company has a market value of around £3.1 billion. It has more than 2,000,000 employees and employs around 10,000 people. The firm has a long-term contract with the Indian Railways, which is expected to see an increase in its operations in the coming years. It also has an agreement with the Government of India, which will see a reduction in the cost of power and fuel for the next few years, as well as an agreement for the sale of some of its non-core assets to the Railways. It is also expected that the government will increase its shareholding in the company to 50% from the current 50%. The company also plans to sell off some of it’s non-essential assets in the near future, including power, fuel and power plants. The sale of these assets is likely to lead to a reduction of the company’s share value.
